TickerFacts.

Mimedx Group, Inc. (MDXG): Total Assets

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2016-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$342.65M
As of 2025-12-31
$281.00M
As of 2026-06-30
+26.0%
3-year compound annual growth
+11.1%
5-year compound annual growth
2010-12-31: $7.35M2011-12-31: $27.10M2012-12-31: $35.18M2013-12-31: $84.69M2014-12-31: $109.26M2015-12-31: $135.91M2016-12-31: $117.27M2017-12-31: $121.25M2018-12-31: $122.84M2019-12-31: $167.17M2020-12-31: $202.03M2021-12-31: $187.93M2022-12-31: $171.43M2023-12-31: $239.05M2024-12-31: $263.92M2025-12-31: $342.65M$342.65M
2010-12-31 Total Assets (USD) 2025-12-31
Period endedTotal AssetsChange YoYSource filing
2025-12-31$342.65M+29.8%2026-02-25, Balance as of period end
2024-12-31$263.92M+10.4%2026-02-25, Balance as of period end
2023-12-31$239.05M+39.4%2025-02-26, Balance as of period end
2022-12-31$171.43M-8.8%2024-02-28, Balance as of period end
2021-12-31$187.93M-7.0%2023-02-28, Balance as of period end
2020-12-31$202.03M+20.9%2022-02-28, Balance as of period end
2019-12-31$167.17M+36.1%2021-03-08, Balance as of period end
2018-12-31$122.84M+1.3%2020-07-06, Balance as of period end
2017-12-31$121.25M+3.4%2020-03-17, Balance as of period end
2016-12-31$117.27Mn/c2020-03-17, Balance as of period end
2015-12-31$135.91M+24.4%2017-03-01, Balance as of period end
2014-12-31$109.26M+29.0%2017-02-22, Balance as of period end
2013-12-31$84.69M+140.7%2015-03-13, Balance as of period end
2012-12-31$35.18M+29.8%2014-03-04, Balance as of period end
2011-12-31$27.10M+268.5%2013-03-15, Balance as of period end
2010-12-31$7.35Mn/a2012-03-29, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
Mimedx Group, Inc. (MDXG)2025-12-31$342.65M+29.8%
Accuray Inc (ARAY)2026-06-30$443.68M-5.6%
Artivion, Inc. (AORT)2025-12-31$884.80M+12.1%
Glaukos Corp (GKOS)2025-12-31$893.49M-8.3%
Tactile Systems Technology Inc (TCMD)2025-12-31$273.94M-8.0%
AtriCure, Inc. (ATRC)2025-12-31$654.18M+7.4%
Angiodynamics Inc (ANGO)2026-05-31$267.16M-4.6%
Bioventus Inc. (BVS)2025-12-31$683.56M-6.1%
PROCEPT BioRobotics Corp (PRCT)2025-12-31$508.08M-4.9%

Compare MDXG, ARAY, AORT, GKOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗